The Technical Analyst
Tandem Diabetes Care Inc [TNDM]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Tandem Diabetes Care Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
10.21% $34.97
America/New_York / 23 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 257.79 mill |
| EPS: | -3.43 |
| P/E: | -10.20 |
| Earnings Date: | May 02, 2024 |
| SharesOutstanding: | 64.56 mill |
| Avg Daily Volume: | 1.723 mill |
| RATING 2024-04-23 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Neutral | |
| DE: | Strong Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -10.20 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.05x |
| Company: PE -10.20 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-0.495 (-101.42%) $-35.47 |
| Date: 2024-04-23 |
| Expected Trading Range (DAY) |
|---|
|
$ 33.01 - 36.95 ( +/- 5.64%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-15 | Carpenter Rick | Buy | 405 | Common Stock |
| 2024-03-15 | Carpenter Rick | Sell | 145 | Common Stock |
| 2024-03-15 | Carpenter Rick | Sell | 405 | Restricted Stock Unit |
| 2024-02-27 | Morrison Susan | Buy | 407 | Common Stock |
| 2024-02-27 | Morrison Susan | Sell | 113 | Common Stock |
| INSIDER POWER |
|---|
| 62.97 |
| Last 100 transactions |
| Buy: 113 075 | Sell: 24 727 |
Forecast:
16:00 - $34.93
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $34.93
Forecast 2: 16:00 - $34.93
Forecast 3: 16:00 - $34.93
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $34.97 (10.21% ) |
| Volume | 2.35 mill |
| Avg. Vol. | 1.723 mill |
| % of Avg. Vol | 136.30 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For TNDM
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $23.22 | N/A | Active |
|---|
TNDM
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Latest Press Releases
2024-04-09 16:05:00 - Press Release
Tandem Diabetes Care To Announce First Quarter 2024 Financial Results On May 2, 2024
San diego--(business wire)--tandem diabetes care, inc. (nasdaq: tndm), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on thursday, may 2, 2024. the company will hold a conference call and simultaneous webcast on the same day at 4:30 pm eastern time (1:30 pm pacific time), to discuss its first quarter 2024 financial and operating results. a live webcast of the call will be available on tandem diabetes.
2024-03-06 00:46:00 - Press Release
Tandem Diabetes Care Prices Upsized Private Placement Of $275.0 Million Of Convertible Senior Notes Due 2029
San diego--(business wire)--tandem diabetes care, inc. (nasdaq: tndm), a global insulin delivery and diabetes technology company, announced today the pricing of $275.0 million aggregate principal amount of 1.50% convertible senior notes due 2029 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to rule 144a under the securities act of 1933, as amended (the “securities act”). the offering was upsized from the previo.
2024-03-04 16:05:00 - Press Release
Tandem Diabetes Care Announces Proposed Private Placement Of Convertible Notes
San diego--(business wire)--tandem diabetes care, inc. (nasdaq: tndm), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions and other factors, $250.0 million aggregate principal amount of its convertible senior notes due 2029 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to rule 144a under the securities act of 1933, as amended (the “s.
2024-02-21 16:05:00 - Press Release
Tandem Diabetes Care Announces Fourth Quarter And Full Year 2023 Financial Results And 2024 Financial Guidance
San diego--(business wire)-- #tandemdiabetes--tandem diabetes care, inc. (nasdaq: tndm), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended december 31, 2023 and provided its financial guidance for the year ending december 31, 2024. fourth quarter and recent highlights worldwide installed base increased 7 percent to approximately 452,000 in-warranty customers compared to the fourth quarter 2022. launched tandem mobi, the world's smallest.
2024-02-13 08:30:00 - Press Release
Tandem Diabetes Care Launches Tandem Mobi, The World's Smallest, Durable Automated Insulin Delivery System
San diego--(business wire)---- $tndm #diabetes--tandem mobi, the world's smallest, durable automated insulin delivery system for people living with diabetes, now shipping in the united states.
Latest News
2024-04-09 16:05:00 - Business Wire
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2024 financial and operating results. A live webcast of the call will be available on Tandem Diabetes.
2024-04-07 12:07:00 - The Motley Fool
1 Beaten-Down Stock That Could Make You Richer
Tandem Diabetes Care is facing economic issues affecting its financial results. The company has the tools to bounce back, including a recently launched device.
2024-04-01 11:46:24 - Zacks Investment Research
Tandem Diabetes (TNDM) Gains From Innovation Amid Macro Issues
Tandem Diabetes (TNDM) seeks to grow its business through the acquisition of products or technologies and investments in businesses.
2024-03-26 15:05:44 - The Motley Fool
Why Tandem Diabetes Care Stock Was Zooming Higher Today
An analyst upgraded his recommendation on the diabetes care specialist. He now rates it a buy, with potential 11% upside to the current share price.
2024-03-22 13:26:06 - Zacks Investment Research
Tandem Diabetes (TNDM) Gains From Innovation Amid Competition
Tandem Diabetes (TNDM), in 2024, intends to advance its AID algorithm and expand its indications to include people living with Type 2 diabetes.
2024-03-22 12:36:35 - Zacks Investment Research
Why Is Tandem Diabetes Care (TNDM) Up 27.4% Since Last Earnings Report?
2024-03-20 16:30:00 - InvestorPlace
Shhh! 7 Small-Cap Stocks That Can Double by 2025
Small cap stocks like those discussed below tend to receive much less attention than their large cap competitors. Shares, which boast a market capitalization between $250 million and $2 billion, remain relatively small.
2024-03-19 09:16:05 - Zacks Investment Research
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
2024-03-08 07:21:15 - Zacks Investment Research
Tandem Diabetes Care, Inc. (TNDM) Surges 9.6%: Is This an Indication of Further Gains?
Tandem Diabetes Care, Inc. (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
2024-02-22 18:55:45 - The Motley Fool
Why Tandem Diabetes Care Stock Popped Today
Tandem Diabetes delivered weaker-than-expected Q4 results but followed with strong forward guidance. The company launched four new products in the U.S. last quarter.